Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-231-1 | CAS number: 5726-19-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity: oral: Test method EEC B.1. GLP study. The acute oral LD50 for 2-methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
Acute toxicity: inhalation: Test method EEC B.2. GLP study. The acute 4h-LD50 for 2-methylcyclohexyl acetate was determined to be >5.32 mg/L of air in rats.
Acute toxicity: dermal: Test method EEC B.3. GLP study. The acute dermal LD50 for 2-methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 30, 1996 - August 13, 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Ltd, Bicester, Oxon, England.
- Age at study initiation: 4-7 weeks
- Weight at study initiation: 90-103 g
- Fasting period before study: Food was only prevented overnight prior to and approximately 4 hours after dosing.
- Housing: Five rats per sex, in metal cages with wire mesh floors.
- Diet (e.g. ad libitum): Ad libitum (SDS LAD 1).
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±3 ºC
- Humidity (%): Not controlled but anticipated in the range of 30-70%.
- Air changes (per hr): 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours dark / 12 hours light (artificial light). - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2.1 ml/kg bw
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 animals per sex and per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality: at least twice daily
Clinical signs: soon after dosing, every 4 hours during day 1, twice daily on subsequent days (with exception of day 15, morning only).
Body weight: day 1 (prior to dosing), day 8 and 15 or at death.
- Necropsy of survivors performed: yes, all animals surviving treatment were killed on day 15 by cervical dislocation.
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Macroscopic pathology: opening the cranial, abdominal and thoracic cavities, and macroscopic appearance of all tissues. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One female rat died shortly after dosing.
- Clinical signs:
- other: Clinical signs prior to death were piloerection and increased salivation. Piloerection persisted on day 1 and was accompanied by hunched posture, waddling gait, lethargy, decreased respiration, partially closed eyelids, pallor of extremities, unsteadiness
- Gross pathology:
- Female rat dead shortly after dosing: Congestion of stomach (characterised by injected blood vessels), duodenum and small intestine. The stomach contained a clear liquid (assumed to be the test material).
Animals killed on day 15: No macroscopic abnormalities were observed. - Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 for 2-methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
- Executive summary:
An acute oral toxicity test was performed on 2 -methylcyclohexyl acetate in accordance with EEC method B.1. Five male and five female rats were exposed to 2000 mg/kg bw by gavage. Mortality, clinical signs and bodyweight were observed for 14 days after dosing. All animals surviving were killed on day 15 and macroscopic examinations were conducted. One female rat died shortly after dosing (macroscopic examination revealed congestion of the stomach, duodenum and small intestine). Clinical signs were observed but recovery was complete by day 4. No macroscopic abnormalities were observed for animals killed on day 15. Based on these result the acute oral LD50 for 2 -methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is a GLP compliant and has a Klimisch score 1. The quality of the database was determined as appropriate for assessment.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 8, 1997 - February 4, 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd, Manston Road, Margate, Kent, England.
- Weight at study initiation: males: 248-281 g; females: 196-230 g.
- Housing: By sex in groups of 5. Stainless steel sheet and wire mesh cages, 35cm x 53cm x 25cm.
- Diet (e.g. ad libitum): Ad libitum (SDS RM1)
- Water (e.g. ad libitum): Ad libitum (tap water)
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16-22 ºC
- Humidity (%): 36-58%
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light (artificial light, 8 am - 8 pm). - Route of administration:
- other: inhalation: liquid droplet aerosol and vapour.
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Aerosol generator
- Exposure chamber volume: Snout-only exposure chamber (ADG Developments), cylindrical form (30 cm i.d., 45 cm height), made of aluminium alloy, with and enclosed volume of approx. 30 litres.
- Method of holding animals in test chamber: The rats were held in moulded polycarbonate restraining tubes which were attached at evenly spaced ports in the cylindrical section of the chamber. Each rat was restrained in a forward position by an adjustable foamed plastic stopper.
- Source and rate of air: A supply of clean dried air was connected to the aerosol generator giving a flow rate of 15 litres/minute at the atomising jet. The test item was introduced into the generator through a syringe pump, with an initial flow rate of 0.3 ml/minute. This flow rate was expected to give a concentration of 2-methylcyclohexyl acetate in air slightly in excess of 5 mg/L. Equilibration period: 5 minutes.
- Treatment of exhaust air: Each chamber was equipped with an extract fan exhausting to atmosphere through an absolute filter.
- Temperature, humidity, pressure in air chamber:
Temperature (mean): 20 ºC (both control and treatment chambers)
Relative humidity (mean): 42 % (control), 45 % (treatment)
TEST ATMOSPHERE
- Brief description of analytical method used:
Test item concentration in the chamber: Gas chromatography (Hewlett Packard 5890A fitted with a model 7673 autosampler). Five samples (every 30 minutes) were taken during the exposure.
Particle size distribution: Two additional samples (at 90 and 210 minutes following the equilibration period) were taken during the exposure.
The nominal concentration was calculated from the amount of 2-methylcyclohexyl acetate dispersed in the generator and the total air flow through the generator during exposure. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- (see above)
- Duration of exposure:
- 4 h
- Concentrations:
- 0 (control), 5.32 mg/L
- No. of animals per sex per dose:
- 5 animals per sex and per dose
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality and clinical signs: at the end of chamber equilibration period, at 0.25, 0.5 and 1.0 hours and then at hourly intervals during the exposure. During the observation period, once in the morning and then as necessary following a later check.
Body weight: daily from the day of delivery until the end of the observation period.
Food and water consumption: daily from the day of arrival.
- Necropsy of survivors performed: yes, at the end of the 14-day observation period by intraperitoneal injection of pentobarbitone sodium and exsanguinated when clinically dead.
Gross pathology: all rats were subjected to a detailed macroscopic examination.
Organ weights: lungs
Histopathology: lungs, liver and kidneys (buffered 10% formalin) - Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.32 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- There were no deaths.
- Clinical signs:
- other: There were no clinical signs during the exposure nor observation periods related to treatment.
- Body weight:
- The rate of bodyweight gain for rats following the exposure was similar to that of the control rats.
- Gross pathology:
- There were no macroscopic abnormalities in test or control rats.
- Other findings:
- - Food and water consumption: A slight reduction in the food consumption of male test rats was recorded for 1 day following exposure, but were otherwise similar to the control values.
- Organ weights: The mean lung weights for male and female test rats were similar to the respective control values.
- Histopathology: no data available. - Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The acute 4h-LD50 for 2-methylcyclohexyl acetate was determined to be >5.32 mg/L of air in rats.
- Executive summary:
An acute inhalation toxicity test was performed on 2 -methylcyclohexyl acetate in accordance with EEC method B.2. Five rats per sex were exposed to the test item for 4 hours in a snout-only exposure system (liquid droplets aerosol and vapour). The concentration of 2 -methylcyclohexyl acetate was 5.32 mg/L. An additional group of control rats (five male and five females) was exposed to air only for 4 hours. The groups were observed for 14 days post-exposure and necropsy was performed at study termination. There were no deaths nor clinical signs during and following exposure. The rate of bodyweight gain for test rats was similar to that of the control rats. A slight reduction in food consumption was recorded for male rats on the day following exposure but were otherwise similar to that of the control rats. The lung weights were similar to control values and there were no macroscopic abnormalities. Based on these results, the acute 4h-LC50 for 2 -methylcyclohexyl acetate was determined to be >5.32 mg/L of air in rats.
Reference
Concentration of 2 -methylcyclohexyl acetate in the chamber air: 5.32 ± 0.230 mg/L
Nominal concentration: 20.3 mg/L
Particle size distribution: c.a. 85% of the test atmosphere was present as vapour or droplets of a respirable size (<6 mm).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 0.005 mg/m³ air
- Quality of whole database:
- The study is a GLP compliant and has a Klimisch score 1. The quality of the database was determined as appropriate for assessment.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 15, 1996 - August 29, 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Ltd, Bicester, Oxon, England.
- Age at study initiation: 7-10 weeks
- Weight at study initiation: 214-287 g
- Housing: individually in metal cages with wire mesh floors.
- Diet (e.g. ad libitum): Ad libitum (SDS LAD 1).
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 28 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±3 ºC
- Humidity (%): Not controlled but anticipated in the range of 30-70%.
- Air changes (per hr): 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours dark / 12 hours light (artificial light). - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 50 mm x 50 mm (dorso-lumbar region). One day prior to treatment hair was removed with electric clippers.
- % coverage: 10% of the total body surface
- Type of wrap if used: the treated area was promptly covered with gauze which was held in place with a non-irritative dressing encircled firmly around the trunk.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): After treatment, the treated area was washed with warm (30-40 ºC) water and blotted dry with absorbent paper.
- Time after start of exposure: 24 hours.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2.09 ml/kg bw - Duration of exposure:
- 24 hours.
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 rats per sex and per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality: at least twice daily
Clinical signs: soon after dosing, every 4 hours during day 1, twice daily on subsequent days (with exception of day 15, morning only).
Body weight: day 1 (prior to dosing), day 8 and 15 or at death.
- Necropsy of survivors performed: yes, all animals surviving treatment were killed on day 15 by cervical dislocation.
Macroscopic pathology: opening the abdominal and thoracic cavities, and macroscopic appearance of all organs.
- Others: Local dermal irritation at the treatment site was assessed daily by draize scoring method (erythema and oedema). - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths.
- Clinical signs:
- other: There were no signs of systemic reaction to treatment.
- Gross pathology:
- No macroscopic abnormalities were observed at necropsy.
- Other findings:
- - Other observations: Slight irritation (grade 1 or 2 erythema/oedema) was evident in two female animals following removal of the dressing. This was fully resolved by the following day in one animal and by day 6 in the remaining animal.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The acute dermal LD50 for 2-methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
- Executive summary:
An acute dermal toxicity test was performed on 2 -methylcyclohexyl acetate in accordance with ECC method B.3. Five male and five female rats were given a single dermal application of 2000 mg/kg bw test item. Mortality, clinical signs, bodyweight and dermal responses were observed for 14 days after dosing. All animals surviving were killed on day 15 and macroscopic examinations were conducted. There were no deaths and no signs of systemic reactions to treatment. Slight irritation was evident in two female rats following removal, and were fully resolved by the following day and by day 6 respectively. A loss of body weight was only recorded for one female rat on day 8. No abnormalities were observed at the macroscopic examinations. One female rat died shortly after dosing (macroscopic examination revealed congestion of the stomach, duodenum and small intestine). Based on these result the acute dermal LD50 for 2 -methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is a GLP compliant and has a Klimisch score 1. The quality of the database was determined as appropriate for assessment.
Additional information
Acute toxicity: oral. Key study: An acute oral toxicity test was performed on 2 -methylcyclohexyl acetate in accordance with EEC method B.1. Clinical signs were observed but recovery was complete by day 4. No macroscopic abnormalities were observed for animals killed on day 15. The acute oral LD50 for 2 -methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
Acute toxicity: inhalation. Key study: An acute inhalation toxicity test was performed on 2 -methylcyclohexyl acetate in accordance with EEC method B.2. There were no deaths nor clinical signs during and following exposure. There were no macroscopic abnormalities. The acute 4h-LC50 for 2 -methylcyclohexyl acetate was determined to be >5.32 mg/L of air in rats.
Acute toxicity: dermal. Key study: An acute dermal toxicity test was performed on 2 -methylcyclohexyl acetate in accordance with EEC method B.3. There were no deaths and no signs of systemic reactions to treatment. Slight irritation was evident in two female rats following removal, and were fully resolved by the following day and by day 6 respectively. No abnormalities were observed at the macroscopic examinations. The acute dermal LD50 for 2 -methylcyclohexyl acetate was determined to be >2000 mg/kg bw in rats.
Justification for selection of acute toxicity – oral endpoint
Only one study available.
Justification for selection of acute toxicity – inhalation endpoint
Only one study available.
Justification for selection of acute toxicity – dermal endpoint
Only one study available
Justification for classification or non-classification
Taking into account the available data, acute oral LD50 > 2000 mg/kg bw, acute dermal LD50 >2000 mg/kg bw and inhalation 4h-LC50 > 5.32 mg/L (mists), the substance is not classified according to CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.